GlassScriptPhysician profile
Derrick Lamar Reedus
NPI 1194929463
$4,643.85
in general payments reported to CMS, 2019-2025
20 companies · $2,030 in 2025
The $2,030 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $877 · 2020: $246 · 2021: $235 · 2022: $381 · 2023: $19.61 · 2024: $856 · 2025: $2,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,947 · Food and Beverage: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,947.27 |
| Food and Beverage | $958.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,957.40 | 2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $855.77 | 2024 | Aquabeam System |
| Medtronic USA, INC. | $585.79 | 2019 | |
| Astellas Pharma US INC | $479.92 | 2019-2022 | |
| Medtronic, INC. | $131.62 | 2022 | |
| Pfizer INC. | $119.57 | 2019-2022 | |
| Coloplast Corp | $76.80 | 2019-2021 | |
| Lumenis, INC | $72.62 | 2021 | |
| Boston Scientific Corporation | $65.51 | 2019-2022 | |
| Abbvie INC. | $53.87 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $49.12 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $30.74 | 2019 | |
| Allergan, INC. | $29.94 | 2020-2021 | |
| Janssen Biotech, INC. | $25.74 | 2019 | |
| Laborie Medical Technologies Corp. | $24.55 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $23.63 | 2025 | |
| Tolmar, INC. | $19.61 | 2023 | |
| Endo Pharmaceuticals INC. | $17.01 | 2019 | |
| Amgen INC. | $12.52 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Reedus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.